These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 13996898)

  • 1. [Current possibility of thrombolytic treatment].
    VERSTRAETE M; AMERY A
    Brux Med; 1962 Dec; 42():1437-54. PubMed ID: 13996898
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and pathological studies: thrombolytic activity and related phenomena.
    VERSTRAETE M
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():328-9. PubMed ID: 13996899
    [No Abstract]   [Full Text] [Related]  

  • 3. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

  • 4. THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.
    FLETCHER AP; ALKJAERSIG N; SHERRY S; GENTON E; HIRSH J; BACHMANN F
    J Lab Clin Med; 1965 May; 65():713-31. PubMed ID: 14281368
    [No Abstract]   [Full Text] [Related]  

  • 5. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY.
    HUME M
    J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458
    [No Abstract]   [Full Text] [Related]  

  • 6. EFFECTS OF FIBRINOLYTIC AGENTS ON EXPERIMENTAL AND CLINICAL THROMBOSIS.
    TSAPOGAS MJ
    J Clin Pathol; 1964 May; 17(3):360-1. PubMed ID: 14159483
    [No Abstract]   [Full Text] [Related]  

  • 7. [ON THE PERFORMANCE OF THROMBOLYTIC TREATMENT WITH STREPTOKINASE].
    WINCKELMANN G; HELMS M
    Med Klin; 1963 Sep; 58():1568-71. PubMed ID: 14050317
    [No Abstract]   [Full Text] [Related]  

  • 8. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 9. Assay of thrombolytic ('fibrinolytic') mixtures intended for therapeutic use.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Lab Clin Med; 1961 Apr; 57():620-9. PubMed ID: 13700257
    [No Abstract]   [Full Text] [Related]  

  • 10. FURTHER EXPERIENCE WITH STREPTOKINASE AS THROMBOLYTIC AGENT.
    AMERY A; VERMYLEN J; MAES H; VERSTRAETE V
    Sangre (Barc); 1964; 61():9-11. PubMed ID: 14214896
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE TREATMENT OF THROMBOSES BY LOCAL INFUSION OF FIBRINOLYTIC ENZYMES].
    BENZER H; BLUEMEL G; GOTTLOB R; PIZA F
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963 Nov; 304():775-80. PubMed ID: 14120202
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
    HELLE I; AAS K; GODAL HC
    Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607
    [No Abstract]   [Full Text] [Related]  

  • 13. AN IN VITRO STUDY OF FIBRINOLYTIC AGENTS ON V2 CARCINOMA CELLS AND INTRAVASCULAR THROMBI IN RABBITS.
    JOHNSON JH; WOODS JR
    Bull Johns Hopkins Hosp; 1963 Dec; 113():335-46. PubMed ID: 14089496
    [No Abstract]   [Full Text] [Related]  

  • 14. [Research on the antifibrinolytic effect of 6-aminocaproic acid. III. Effect of 6-aminocaproic acid as an antidote to thrombolytic agents (plasmin, streptokinase)].
    GIBELLI A
    Gazz Int Med Chir; 1962 Nov; 66():2444-50. PubMed ID: 13947688
    [No Abstract]   [Full Text] [Related]  

  • 15. PITFALLS IN THE THROMBOLYTIC TREATMENT OF VENOUS OCCLUSION.
    AMERY A; VERMYLEN J; MAES H; VERSTRAETE M
    Vasc Dis; 1964 Mar; 1():89-93. PubMed ID: 14186547
    [No Abstract]   [Full Text] [Related]  

  • 16. [PRESENT STATUS OF THROMBOLYTIC THERAPY].
    VAIREL EG; ANTOINE G
    Sangre (Barc); 1964; 41():441-6. PubMed ID: 14248832
    [No Abstract]   [Full Text] [Related]  

  • 17. Streptokinase as a thrombolytic agent.
    JOHNSON AJ; McCARTY WR
    Am J Cardiol; 1960 Aug; 6():487-95. PubMed ID: 14407414
    [No Abstract]   [Full Text] [Related]  

  • 18. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
    CLIFFTON EE
    Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024
    [No Abstract]   [Full Text] [Related]  

  • 19. [CURRENT POSSIBILITIES AND COMPLICATIONS OF THROMBOLYTIC TREATMENT].
    VERSTRAETE M; AMERY A; VERMYLEN J
    Acta Chir Belg; 1963 Sep; 62():674-6. PubMed ID: 14089251
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness of activators in clot lysis, with special reference to fibrinolytic therapy. A new method for determination of preformed clot lysis.
    BLIX S
    Acta Med Scand Suppl; 1962; 386():1-24. PubMed ID: 13971658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.